We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

By HospiMedica International staff writers
Posted on 19 Jul 2024
Print article
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage transcatheter mitral valve replacement (TMVR) company. Innovalve, founded in 2017 at ARC Innovation, the innovation arm of Sheba Medical Center (Ramat Gan, Israel), has demonstrated progress in its program with promising early clinical experience since its initial investment by Edwards.

Innovalve was created by the pioneering efforts of Prof. Ehud Raanani, Director of Sheba’s Cardiovascular and Thoracic Center, and Dr. Boris Orlev, Head of Sheba’s Mitral Valve Surgery Unit. Under the leadership of CEO Eyal Bar-Or, Innovalve has benefited from close collaboration with Sheba’s clinicians and developers. This acquisition marks a significant step in the integration of cutting-edge technologies into Edwards’ transcatheter mitral and tricuspid therapies (TMTT) product group. Combined with Edwards’ existing mitral innovations, the acquisition enhances the company’s TMVR technologies to address large unmet structural heart patient needs and support sustainable long-term growth. Edwards is developing a portfolio of transcatheter repair and replacement therapies designed to address mitral and tricuspid valve diseases. The company is committed to transforming the treatment of mitral and tricuspid patients, supported by a robust body of clinical evidence. The acquisition is expected to close by the end of 2024.

“Building on our learnings of the complexity of mitral disease, we know there is a need for a differentiated range of therapies for these patients,” said corporate vice president, Daveen Chopra who leads the TMTT product group at Edwards. “Edwards’ SAPIEN M3 remains on track to become the first approved transfemoral TMVR system in Europe by the end of 2025. We believe the Innovalve technologies, paired with Edwards’ deep mitral expertise, will enable a TMVR platform that will expand the treatable population.”

“The health system is an engine of economic growth for the Israeli economy. Innovalve’s exit joins other Sheba companies acquired in recent months by international biomed giants, which have repeatedly expressed confidence in innovation coming out of Sheba,” said Prof. Yitshak Kreiss, Director General of Sheba Medical Center. “These achievements are made possible thanks to ARC – Sheba’s unique innovation platform, which encourages the development of groundbreaking technologies through the combination of technological entrepreneurship and extensive clinical knowledge and experience at the patient’s bedside. Soon we will see more and more deals of this kind, the fruits of which strengthen and develop the public health system. This is a real revolution that transforms the health system, which for years had to budget for the state, into a factor that generates significant revenues for the Israeli economy.”

Related Links:
Edwards Lifesciences 
Innovalve Bio Medical LTD.
Sheba Medical Center

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Electric Cast Saw
CC4 System
New
Vertebral Body Replacement System
Hydrolift

Print article

Channels

Critical Care

view channel
Image: Changes in immune cells can predict patient recovery following out-of-hospital cardiac arrest (Photo courtesy of Adobe Stock)

Activating T Cells Could Improve Neurological Outcomes After Cardiac Arrest

Despite advancements in cardiopulmonary resuscitation (CPR) and improved hospital access, survival rates after out-of-hospital cardiac arrest (OHCA) remain low, with only about 10% of patients surviving.... Read more

Surgical Techniques

view channel
Image: (Left) An image of a 3D-printed material implanted in vivo for 4 weeks. (Right) A photo of coral (Photo courtesy of Dr Zhidao Xia and Jesus Cobaleda)

Revolutionary Coral-Inspired Material for Bone Repair Promotes Faster Healing

Bone defects caused by fractures, tumors, and non-healing injuries are major contributors to disability worldwide. Traditionally, doctors have used either a patient’s own bone (autograft) or donor bone... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.